SynthesisHuman vaccines & immunotherapeutics2025
Disease burden of seasonal influenza in China from 2010 to 2019: A systematic review and meta-analysis based on multiple indicators.
Synthesis in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The economic burden of seasonal influenza - China, 2010-2019.Human vaccines & immunotherapeutics · 2026Article
- Article
- Article
- Comparative analysis of influenza epidemiological characteristics in Quzhou, China from 2016 to 2024.Annals of medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Through systematic review and meta-analysis, the average annual disease burden of seasonal influenza in China from 2010 to 2019 was estimated, and the differences between the northern and the southern regions were compared. A systematic review was conducted to collect articles from 2010 to 2019 on the disease burden of seasonal influenza in China. Study quality was assessed using the cross-sectional appraisal tool from the Agency for Healthcare Research and Quality. Relevant data were extracted, and a random-effects model was used to produce age-stratified estimates for each metric. From these, the average annual number of influenza cases and excess deaths were calculated. A subgroup analysis compared northern and southern regions to account for possible regional differences. All statistical analyses were conducted using R software. A total of 24 articles were included. The annual average number of influenza cases is 111,429,687 (95%CI: 82,372,516-154,937,609). The burden of influenza, in terms of incidence rates, outpatient rates, and hospitalization rates, was heaviest among children under 5 years old. The burden of excess mortality was the heaviest among the elderly ≥65years old. Except for the incidence rates and hospitalization rates of individual age groups, there were no significant north-south differences in most epidemiological indicators. The study obtains the average annual disease burden of seasonal influenza. The disease burden of children <5years old and the elderly is relatively heavier. The study provides valuable evidence for the prevention and control of seasonal influenza.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.